These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 26490786)
1. Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22). Ryan NM; Kearney RT; Brown SG; Isbister GK Clin Toxicol (Phila); 2016; 54(1):27-33. PubMed ID: 26490786 [TBL] [Abstract][Full Text] [Related]
2. Incidence of serum sickness following Indian polyvalent antivenom therapy in a cohort of snake-envenomed patients in rural Sri Lanka. Waiddyanatha S; Silva A; Wedasingha S; Siribaddana S; Isbister GK Clin Toxicol (Phila); 2023 Jul; 61(7):518-523. PubMed ID: 37486099 [TBL] [Abstract][Full Text] [Related]
3. The Australian Snakebite Project, 2005-2015 (ASP-20). Johnston CI; Ryan NM; Page CB; Buckley NA; Brown SG; O'Leary MA; Isbister GK Med J Aust; 2017 Aug; 207(3):119-125. PubMed ID: 28764620 [TBL] [Abstract][Full Text] [Related]
4. Bites in Australian snake handlers--Australian snakebite project (ASP-15). Isbister GK; Brown SG; QJM; 2012 Nov; 105(11):1089-95. PubMed ID: 22875778 [TBL] [Abstract][Full Text] [Related]
5. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19). Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK; Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640 [TBL] [Abstract][Full Text] [Related]
6. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Isbister GK; Brown SG; MacDonald E; White J; Currie BJ; Med J Aust; 2008 Apr; 188(8):473-6. PubMed ID: 18429716 [TBL] [Abstract][Full Text] [Related]
7. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12). Isbister GK; White J; Currie BJ; O'Leary MA; Brown SG; Toxicon; 2011 Dec; 58(8):634-40. PubMed ID: 21967812 [TBL] [Abstract][Full Text] [Related]
8. Clinical features of serum sickness after Australian snake antivenom. Ryan NM; Downes MA; Isbister GK Toxicon; 2015 Dec; 108():181-3. PubMed ID: 26525657 [TBL] [Abstract][Full Text] [Related]
9. Antivenom use in Australia. Premedication, adverse reactions and the use of venom detection kits. Sutherland SK Med J Aust; 1992 Dec 7-21; 157(11-12):734-9. PubMed ID: 1360618 [TBL] [Abstract][Full Text] [Related]
10. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25). Johnston CI; Ryan NM; O'Leary MA; Brown SG; Isbister GK Clin Toxicol (Phila); 2017 Feb; 55(2):115-122. PubMed ID: 27903075 [TBL] [Abstract][Full Text] [Related]
11. Tiger snake (Notechis spp) envenoming: Australian Snakebite Project (ASP-13). Isbister GK; O'Leary MA; Elliott M; Brown SG Med J Aust; 2012 Aug; 197(3):173-7. PubMed ID: 22860796 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial and prospective cohort investigating antivenom for red-bellied black snake envenomation. Isbister GK; Jenkins S; Downes MA; Fakes K; Buckley NA Clin Toxicol (Phila); 2024 Jun; 62(6):343-351. PubMed ID: 38913734 [TBL] [Abstract][Full Text] [Related]
13. Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11). Churchman A; O'Leary MA; Buckley NA; Page CB; Tankel A; Gavaghan C; Holdgate A; Brown SG; Isbister GK Med J Aust; 2010 Dec 6-20; 193(11-12):696-700. PubMed ID: 21143062 [TBL] [Abstract][Full Text] [Related]
14. Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Western Australia over 10 years. Yeung JM; Little M; Murray LM; Jelinek GA; Daly FF Med J Aust; 2004 Dec 6-20; 181(11-12):703-5. PubMed ID: 15588174 [TBL] [Abstract][Full Text] [Related]
15. Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming--Australian snakebite project (ASP-14). Allen GE; Brown SG; Buckley NA; O'Leary MA; Page CB; Currie BJ; White J; Isbister GK; PLoS One; 2012; 7(12):e53188. PubMed ID: 23300888 [TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18). Isbister GK; Buckley NA; Page CB; Scorgie FE; Lincz LF; Seldon M; Brown SG; J Thromb Haemost; 2013 Jul; 11(7):1310-8. PubMed ID: 23565941 [TBL] [Abstract][Full Text] [Related]
17. Safety profile of snake antivenom (use) in Hong Kong - a review of 191 cases from 2008 to 2015. Mong R; Ng VCH; Tse ML Clin Toxicol (Phila); 2017 Dec; 55(10):1066-1071. PubMed ID: 28657429 [TBL] [Abstract][Full Text] [Related]
18. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis. Schaeffer TH; Khatri V; Reifler LM; Lavonas EJ Acad Emerg Med; 2012 Feb; 19(2):121-31. PubMed ID: 22320362 [TBL] [Abstract][Full Text] [Related]
19. Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16). Johnston CI; O'Leary MA; Brown SG; Currie BJ; Halkidis L; Whitaker R; Close B; Isbister GK; PLoS Negl Trop Dis; 2012; 6(9):e1841. PubMed ID: 23029595 [TBL] [Abstract][Full Text] [Related]
20. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. León G; Herrera M; Segura Á; Villalta M; Vargas M; Gutiérrez JM Toxicon; 2013 Dec; 76():63-76. PubMed ID: 24055551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]